Mark E. Strome - Nov 14, 2022 SCHEDULE 13G/A Report for Cue Biopharma, Inc. Common Stock, $0.001 par value per share (CUE)

Filing Manager
Mark E. Strome
Reporting Manager
Mark E. Strome
Security
Cue Biopharma, Inc. Common Stock, $0.001 par value per share
Symbol
CUE
Shares outstanding
43.4M shares
Disclosed Ownership
2.17M shares
Ownership
4.99%
Form type
SCHEDULE 13G/A
Date filed
5/16/2025, 04:01 PM
Date of event
Nov 14, 2022
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Mark E. Strome 4.99% 2.17M 50.2K 2.12M /s/ Mark E. Strome Mark E. Strome
Strome Mezzanine Fund, LP 0.11% 46.1K 0 46.1K /s/ Mark E. Strome President of Strome Group, Inc., the general partner of Strome Investment Management, LP, the general partner of Strome Mezzanine Fund, LP
Strome Mezzanine Fund II, LP 4.39% 1.91M 0 1.91M /s/ Mark E. Strome President of Strome Group, Inc., the general partner of Strome Investment Management, LP, the general partner of Strome Mezzanine Fund II, LP
Strome Dynasty, LLC. 0.38% 163K 0 163K /s/ Mark E. Strome Manager